We compared the growth of Bordetella pertussis strains (n = 32) on antibiotic-free and cephalexin (40 ,ug/ml)-containing charcoal agar supplemented with 10% defibrinated horse blood, defibrinated sheep blood, or anticoagulant-containing human blood. Plates were incubated either in air or in an atmosphere with 5 to 10% C02. As assessed by mean colony numbers and rapidity of growth, normal air was preferable to C02 enrichment for incubation. Growth on horse blood agar was more abundant and more rapid than on sheep blood agar, but the difference in general was not statistically significant. Human blood was clearly inferior to both horse and sheep blood.
Bordetella pertussis has no C02 requirement (4), but some authors have used an atmosphere with 5 to 10% C02 for cultivation (1, 3) . To our knowledge, no study that compares the two incubation atmospheres with respect to charcoal agar has been published (2) .
The manufacturer of charcoal agar base (Oxoid Ltd., Basingstoke, United Kingdom) recommends supplementing the agar with 10% whole defibrinated horse blood. Some authors have used sheep blood instead (1, 3) . Comparative studies of horse and sheep blood seem to be lacking. Since animal blood often is not available to bacteriology laboratories in developing countries, the question of whether human blood can be substituted for it is of practical interest. Donated human blood which for some reason cannot be transfused is often the only source of blood available under such circumstances.
We therefore studied the growth of B. pertussis on antibiotic-free and cephalexin-containing charcoal agar supplemented with horse, sheep, or human blood and incubated either in normal air or in an atmosphere with 5 to 10% C02.
Thirty-two clinical isolates of B. pertussis which had been stored at -70°C in glycerol soon after isolation were thawed and grown on antibiotic-free Jones-Kendrick agar (5) Oxoid charcoal agar was prepared according to the instructions of the manufacturer. After autoclaving and cooling to 50°C, half of the agar was supplemented with 40 ,ug of cephalexin per ml. Both the antibiotic-free and the cephalexin-containing agars were further supplemented with 10% horse blood (Oxoid), 10% sheep blood (Gesellschaft für Mikrobiologische Nahrmedien, Walldorf, Federal Republic of Germany), or 10% human blood (blood groups A1 and B) obtained from the blood bank of Tubingen University Hospitals. The two animal blood products had been defibrinated by use of sterile glass beads; the human blood contained the standard anticoagulant citrate-phosphate-dextrose-adenine. When the media were prepared, appropriate sterility control measures were taken.
Each B. pertussis strain was seeded on two plates of antibiotic-free charcoal-horse blood agar (HA), charcoalsheep blood agar (SA), and charcoal-human blood agar (MA). The same procedure was used for the cephalexincontaining media. Altogether, each strain was inoculated onto 12 plates.
Half of all plates were incubated in normal air at 36°C in a humid environment. The remaining plates were incubated in GasPak jars in 5 to 10% C02 (CO2 Systems Envelope; Becton Dickinson and Co., Cockeysville, Md.). Incubation in both atmospheres was for 5 days. On days 3, 4, and 5, colonies were counted and their development stages were assessed semiquantitatively (1+, tiny colonies; 2+, small colonies [ca. 0.5-mm diameter]; 3+, mature colonies [ca. 1-mm diameter]). For statistical evaluation, the tests of Dixon and Mood (6) and of Bowker (7) were used.
All media supported growth of all strains under both incubation conditions, but there were considerable differences. Table 1 shows the mean colony numbers (MCN) of B. pertussis counted on the various plates on days 3, 4, and 5.
MCN on HA were in general slightly higher than on SA, irrespective of incubation atmosphere and presence of cephalexin. Significantly higher MCN (P < 0.05) on HA were observed only on the antibiotic-free plates incubated in 5 to 10% C02 on days 3 and 4.
MCN on HA and SA were always significantly higher than on MA (P < 0.01), irrespective of atmosphere and antibiotic. MA incubated in 5 to 10% C02 yielded the lowest MCN.
Incubation in 5 to 10% C02 of plates of all three kinds of blood always yielded significantly lower MCN (P < 0.01) than incubation in air of the corresponding plates. This applies both to antibiotic-free and to cephalexin-containing agars.
J. CLIN. MICROBIOL. containing cephalexin, but the difference was not statistically significant for HA and SA, with the exception of SA incubated in air on days 3 (P < 0.02) and 4 (P < 0.05). Table 2 shows the rapidity of growth of B. pertussis as assessed by three stages of colony development. During incubation in air, colony development on HA was in general more rapid than on SA, but statistical significance (P < 0.05) was reached or:iy on day 3 on the antibiotic-free plates.
During incubation in air, colony development on HA and SA was always significantly more rapid than on MA, irrespective of antibiotic. On MA incubated in air, B. pertussis never developed mature colonies (3+ by day 5), but on MA incubated in 5 to 10% C02, colony development was even poorer.
On the plates incubated in 5 to 10% CO2, development of mature colonies was never observed (with one exception), irrespective of antibiotic and the kind of blood used.
On cephalexin-containing HA and SA, growth of B. pertussis on days 3 and 5 (but not on day 4) was more advanced than on the corresponding antibiotic-free plates. This observation is not easily explained.
In conclusion, incubation in normal air is clearly preferable to incubation in an atmosphere with enriched C02 for cultivation of B. pertussis. Growth of the organisms on HA was more abundant and more rapid than on SA, but the difference in general was not statistically significant.
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